Iranian Journal of Pharmaceutical Research

1. AML-derived Extracellular Vesicles Confer De Novo Chemoresistance to Leukemic Myeloblast Cells by Promoting Drug Export Genes Expression and ROS Inhibition

Volume 20, Issue 1, Winter 2021, Pages 384-397

Mohieddin Barzegar; Mehdi Allahbakhshian Farsani; Vahid Amiri; Saeed Mohammadi; Shaghayegh Shahsavan; Amin Mirzaeian; Mohammad HosseinMohammadi

View Article
PDF 1.03 MB

2. CDK Blockade Using AT7519 Suppresses Acute Myeloid Leukemia Cell Survival through the Inhibition of Autophagy and Intensifies the Anti-leukemic Effect of Arsenic Trioxide

Volume 18, Special Issue, Autumn 2019, Pages 119-131

Mitra Zabihi; Ava Safaroghli-Azar; Ahmad Gharehbaghian; Mehdi Allahbakhshian Farsani; Davood Bashash

View Article
PDF 1.01 MB

3. Evaluation of ATG7 and Light Chain 3 (LC3) Autophagy Genes Expression in Newly Diagnosed AML Patients

Volume 18, Issue 2, Spring 2019, Pages 1060-1066

Mohamadreza Mohamadimaram; Mehdi Allahbakhshian Farsani; Amin Mirzaeian; Shaghayegh Shahsavan; Abbas Hajifathali; Sayeh Parkhideh; Mohammadhossein Mohammadi

View Article
PDF 516.44 K

1. AML-derived Extracellular Vesicles Confer De Novo Chemoresistance to Leukemic Myeloblast Cells by Promoting Drug Export Genes Expression and ROS Inhibition

2. CDK Blockade Using AT7519 Suppresses Acute Myeloid Leukemia Cell Survival through the Inhibition of Autophagy and Intensifies the Anti-leukemic Effect of Arsenic Trioxide

3. Evaluation of ATG7 and Light Chain 3 (LC3) Autophagy Genes Expression in Newly Diagnosed AML Patients

Journal Archive